UK Life Sciences and Healthcare Newsletter: Life Sciences: What's new in France? The Santen case and the notion of second medical use with regards to supplementary protection certificates (SPC): a strict interpretation of the EU regulation
By EsqSocial Corporation 28/01/21
How to interpret the notion of second medical use with regards to SPCs? This is the question which was asked of the Court of Justice of the European Union (CJEU) by the court of appeal of Paris on behalf of the French industrial property office in the Santen case. On July 9, 2020 the CJEU put an end to ten years of legal uncertainty....
By: Dechert LLP